[Screening for neuroblastoma in infants aged 6 months. A method of testing].
In a number of cases, neuroblastoma (NB) may be diagnosed by routine screening of the urine for vanillinic-mandelic acid (VMA) and homovanillinic acid (HVA) in symptomfree infants at the age of six months. Early diagnosis of this disease may possibly improve the prognosis. The object of this project was to establish a method of measuring VMA and HVA concentrations in urine collected on filter paper and to assess participation by the parents as regards three different methods of collecting urine with the object of establishing a population screening programme for NB in Denmark. A total of 1,111 infants aged 6-8 months participated in the investigation. The equipment for testing the urine was given in three different was: 1) By the health nurses (County of Arhus), 2) By the general practitioner at the 6-month vaccination (County of Ringkøbing) and 3) By post (County of Viborg). In Arhus, the health nurses delivered the equipment to 96.7% of the age group concerned. Altogether, urine samples were obtained from 673 infants (61%). Participation was greatest in the County of Arhus (66%) and the County of Ringkøbing (62%) and lowest in the County of Viborg (54%). Two infants were found with marginally raised VMA or HVA but these values were found to be normal on repeated examinations. No cases of neuroblastoma were found in the material nor in the screened group in the course of 1 1/2 years after the conclusion of the investigation. In just over 3% of the cases, renewed urine samples had to be sent on account of too little urine on the filter paper. If current population investigations reveal that screening for neuroblastoma can alter the course of the disease in children, the method described here may form the basis for introduction of population investigations in Denmark.
Schrøder
H
H
Paediatrisk afdeling og klinisk kemisk afdeling, Arhus Kommunehospital.
Møller
J
J
Thomsen
A
A
Skadborg
R
R
Clausen
N
N
D003718:Denmark / Q000453:epidemiology; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D009447:Neuroblastoma / Q000175:diagnosis / Q000453:epidemiology* / Q000652:urine; D011379:Prognosis; D014642:Vanilmandelic Acid / Q000652:urine
D014642:Vanilmandelic Acid; D006719:Homovanillic Acid
Screening for neuroblastom i seks måneders alderen. En metodeafprøvning.